Rajeev Singh, drugs controller general, calls for the Indian pharmaceutical sector to innovate beyond generic drugs to ...

India is showing real commitment to realize its vision of becoming a “pharmacy of the world” by implementing policies and ...

This development underscores India’s commitment to supporting the Global South with affordable healthcare solutions and adds ...

In an effort to provide affordable medicines to the public, more than 10 countries are looking to imbibe India's generic ...

Dr Reddy's Laboratories and FDC Ltd are recalling generic medications in the US market due to manufacturing issues, according ...

Indian generic drugmaker Lupin reported a bigger-than-expected rise in second-quarter profit on Thursday, driven by strong demand for its respiratory and diabetes management drugs.

More than 10 countries are looking to imbibe India's generic pharmacy model to make affordable medicines accessible to the p ...

By Rishika Sadam and Kashish Tandon (Reuters) -Sun Pharmaceuticals, India's largest drugmaker by revenue, reported ...

Indian drugmaker Zydus Lifesciences reported a 14% rise in second-quarter profit on Tuesday, helped by strong demand for generic drugs in its key United States and Indian markets.

Drugs to treat gastrointestinal and cardiovascular diseases, painkillers and anti-diabetic medicines recorded the maximum ...